Investors Economics Commentary Forex Politics Entertainment Content Sales Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Earnings News
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Mobile 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

Font Down Font Up

Law Offices Of Howard G. Smith Files Class Action Lawsuit Against Cell Therapeutics
3/13/2010 10:44 AM  ET
RELATED NEWS
Cell Therapeutics Says FDA Okays Pixantrone Manufacturing Site - Update
Cell Therapeutics Says NerPharMa Gets FDA Approval To Manufacture Drug Pixantrone - Quick Facts
Cell Therapeutics Gets Notification From GOG That Phase III GOG-212 Trial Of OPAXIO Remains High Priority - Quick Facts
Cell Therapeutics Says FDA Set March 22 For ODAC Meeting To Review CTI's NDA For Pixantrone - Quick Facts
Cell Therapeutics Says Its Consolidated Financial Statements For FY09 Contained "going Concern" Qualification - Quick Facts

Trade CTIC now with
TOP MARKET NEWS
Stocks End Nearly Unchanged Following Mixed Economic Data - U.S. Commentary
Pelosi Kills Public Option Despite Senate's Willingness To Fight For It
Congressional Republicans Name Members Of Obama's Deficit Commission
Stocks Nearly Flat In Mid-Afternoon Trading - U.S. Commentary
Stocks Little Changed In Early Afternoon Trading - U.S. Commentary
(RTTNews) -  Saturday, law Offices of Howard G. Smith said a securities class action lawsuit has been filed against Cell Therapeutics, Inc. (CTIC: News ) alleging misrepresentations regarding business and financial prospects.

The complaint alleges that the company violated federal securities laws by issuing material misrepresentations to the market concerning the its business and financial prospects, thereby artificially inflating the price of its securities.
The class action lawsuit was filed on behalf of those who purchased common stock of Cell Therapeutics between May 5, 2009 and February 8, 2010. The lawsuit was filed in the United States District Court for the Western District of Washington. No class has yet been certified for the complaint.

Click here to receive FREE breaking news email alerts for Cell Therapeutics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com


Email        Print           Follow Us RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

  
More Quick Facts
672  Disney Reportedly To Close ImageMovers Digital Studio - Quick Facts
671  Google '99.9%' Certain To Shut Its Search Engine In China:FT - Quick Facts
670  Law Offices Of Howard G. Smith Investigates Potential Claims Against Spark Networks' Board - Quick Facts
669  Refill Energy Signs US$10 Mln Contract With Nueva Esperanza Of Peru - Quick Facts
668  Exeter Resource Gets Shareholders Approval For Spin-out To Create Two Independent Companies - Quick Facts
667  Medtronic Gets Conditional Approval From FDA Panel For Its Deep Brain Stimulation Therapy For Epilepsy - Quick Facts
666  Georox Resources FY09 Net Loss Narrows - Quick Facts
665  Heritage Oaks Bancorp Closes Private Placement - Quick Facts
664  VCG Holding Q4 Loss Narrows - Quick Facts
663  Chai-Na-Ta Turns To Profit In Q4 - Quick Facts
662  GMV Minerals Terminates Agreement To Acquire 100% Interest In Gold Producer In El Oro Province, Ecuador
661  Nortel Networks Turns To Profit In Q4 - Quick Facts
660  Western Pacific Trust Co. Appoints Helen Wong As CFO - Quick Facts
659  U.S. Energy FY09 Loss Widens - Quick Facts
658  Auburn National Bancorp. Revises Q4 And FY09 Earnings - Quick Facts
657  Bird Construction Income Fund Q4 Profit Declines - Quick Facts
656  Ctrip.com Intl. Inks Definitive Agreements For Acquiring Minority Stakes In Two Hotel Operating Companies - Quick Facts
655  Value Line Q3 Profit Declines - Quick Facts
654  PetroBakken Energy Completes Buyout Of Rondo Petroleum Inc. - Quick Facts
653  Loral Space & Communications Swings To Profit In Q4 - Quick Facts
652  CounterPath Q3 Loss Narrows - Quick Facts
651  WGI Heavy Minerals Turns To Profit In Q4 - Quick Facts
650  First United Q4 Profit Widens - Quick Facts
649  Community Financial Shares Revises Q4, FY09 Results - Quick Facts
648  American HomePatient Enters Into Ninth Forbearance Agreement With NexBank

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| How To Use RTTNews.com| Advertise| Privacy| Buy Content | RSS | Mobile